On ECHEMI
Home > Drugs > Di'ao Group Chengdu Pharmaceutical Co., Ltd.
Di'ao Group Chengdu Pharmaceutical Co., Ltd.
  • Founded in:

    1997-07-31
  • Country:

    China China
  • Address:

    No. 518, Herui Road, Chengdu Hi-tech Zone
  • Tax NO.:

    91510100201913965Q
  • Registered Funds:

    71.01 million yuan
  • Website:

  • Email:

Related Drugs
Pyrantel Pamoate Tablets
The main component is pyrantel pamoate. Chemical name: (E)-1-methyl-2-[2-(2-thienyl)vinyl]-1,4,5,6-tetrahydropyrimidine, 4,4'-methylene-bis(3-hydroxy-2-naphthoic acid) salt. Molecular formula: C11H14N2S·C23H16O6. Molecular weight: 594.68
Name Description Content CAS NO. Registered Holders
Pyrantel pamoate

This product is a depolarizing neuromuscular blocker that can cause the parasite to spasm and be excreted from the body. The mechanism of action is: first the parasite contracts significantly, then it becomes paralyzed and immobile.

More

This product is a depolarizing neuromuscular blocker that can cause the parasite to spasm and be excreted from the body. The mechanism of action is: first the parasite contracts significantly, then it becomes paralyzed and immobile.

22204-24-6 9
Famciclovir Tablets
The main ingredient of this product is famciclovir, and its chemical name is 2-[2-(2-amino-9H-purine-9-yl)ethyl]-1,3-propanediol-diethyl ester.
Name Description Content CAS NO. Registered Holders
Famciclovir

It is rapidly converted into the antiviral compound penciclovir in the body, which has an inhibitory effect on herpes simplex virus type Ⅰ (HSV-1), herpes simplex virus type Ⅱ (HSV-2) and varicella zoster virus (VZV). It selectively inhibits the synthesis and replication of herpes virus DNA through phosphorylation of viral thymidine kinase.

More

It is rapidly converted into the antiviral compound penciclovir in the body, which has an inhibitory effect on herpes simplex virus type Ⅰ (HSV-1), herpes simplex virus type Ⅱ (HSV-2) and varicella zoster virus (VZV). It selectively inhibits the synthesis and replication of herpes virus DNA through phosphorylation of viral thymidine kinase.

104227-87-4 17
Benornate Tablets
Benoate
Name Description Content CAS NO. Registered Holders
BENORILATE

This product is a neutral compound of aspirin and acetaminophen bonded by an ester bond. It has antipyretic and analgesic effects, with fewer adverse reactions than aspirin and is easily tolerated by patients. After oral administration, it is not hydrolyzed in the gastrointestinal tract, is absorbed in the intestine and quickly reaches an effective concentration in the blood. It is characterized by rarely causing gastrointestinal bleeding.

More

This product is a neutral compound of aspirin and acetaminophen bonded by an ester bond. It has antipyretic and analgesic effects, with fewer adverse reactions than aspirin and is easily tolerated by patients. After oral administration, it is not hydrolyzed in the gastrointestinal tract, is absorbed in the intestine and quickly reaches an effective concentration in the blood. It is characterized by rarely causing gastrointestinal bleeding.

5003-48-5 12
Benornate Tablets
Benoate
Name Description Content CAS NO. Registered Holders
BENORILATE

This product is a neutral compound of aspirin and acetaminophen bonded by an ester bond. It has antipyretic and analgesic effects, with fewer adverse reactions than aspirin, and is easily tolerated by patients. After oral administration, it is not hydrolyzed in the gastrointestinal tract, is absorbed in the intestine and quickly reaches an effective concentration in the blood, and is characterized by rarely causing gastrointestinal bleeding.

More

This product is a neutral compound of aspirin and acetaminophen bonded by an ester bond. It has antipyretic and analgesic effects, with fewer adverse reactions than aspirin, and is easily tolerated by patients. After oral administration, it is not hydrolyzed in the gastrointestinal tract, is absorbed in the intestine and quickly reaches an effective concentration in the blood, and is characterized by rarely causing gastrointestinal bleeding.

5003-48-5 12
Ofloxacin Tablets
The main ingredient of this product is ofloxacin. Its chemical name is (±)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-[1,4]benzoxazine-6-carboxylic acid.
Name Description Content CAS NO. Registered Holders
Ofloxacin

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial effect on most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good resistance to Chlamydia trachomatis, Mycoplasma and Legionella.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial effect on most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good resistance to Chlamydia trachomatis, Mycoplasma and Legionella.

82419-36-1 30
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.